Biopsy Devices Market Analysis and Forecast To 2024 By Recent Trends, Development and Regional Growth Overview

China biopsy devices market size is pegged to register a 12.1% CAGR up to 2024 due to the expansion of the regional population, mainly the older aged individuals. The increasing rate of cancer cases,  emergence of newer technologies, and multiple growth opportunities across the country will foster the adoption of biopsy devices.

Further, unhealthy dietary habits and sedentary lifestyle have put the spotlight on cancer, thereby impelling industry growth. Awareness pertaining to cancer diagnosis and prevalence of sophisticated diagnostic procedures are expected to influence biopsy devices market forecast. Accordingly, introduction of reimbursement policies such as Medicare reimbursement meant to diagnose cancer will reinforce biopsy devices market size expansion.

Get sample copy of this research report @ https://www.decresearch.com/request-sample/detail/731

Ambulatory surgical centers (ASCs) segment is expected to gain momentum with a healthy CAGR of over 9% during the assessment period. Factors such as low-cost structures and soaring number of procedures performed in ambulatory surgical centers have been a vital cog in the growth of biopsy devices market share. Moreover, it is believed that introduction of health insurance coverage under Affordable Care Act (ACA) will spur biopsy devices market revenue in the ensuing period.

Hospital end-user segment was dominant in 2017 owing to large number of biopsy procedures performed in the landscape. Global Market Insights, Inc. strongly believes that presence of sophisticated biopsy devices will complement highly skilled healthcare professionals, and eventually propel biopsy devices market trends.

With the soaring traction of robotic biopsy guidance systems, biopsy guidance system segment is projected to expand robustly at a CAGR of 7.1% during the assessment period. For instance, market penetration of Hologic’s Affirm breast biopsy guidance system has streamlined biopsy devices with reduced patient dose and lesser number of steps.

Biopsy device manufacturers are implementing numerous marketing strategies like mergers, acquisitions, product launches as well as R&D programs to initiate innovations in the devices, even during and post the COVID-19 pandemic. For instance, Hologic, a global supplier, incorporated the CorLumina imaging technology in its breast biopsy device, Brevera, in August 2020.

DTR Medical, Medtronic, Dickinson and Company, C.R. Bard, B. Braun, Olympus Corporation, Argon Medical Devices and Melsungen AG, Becton, Cardinal Health are some of the other device suppliers in the sector. These firms are also working towards initiatives to expand their reach in the sparsely addressed regions across the world.

Request for a Customization of this research report @ https://www.decresearch.com/roc/731

Partial Chapter of the Table of Content

Chapter 4.  Biopsy Devices Market, By Product

4.1. Key segment trends

4.2. Biopsy guidance systems

4.2.1.  Market size, by region, 2013-2024 (USD Million)

4.2.2.  Manual

4.2.2.1.    Market size, by region, 2013-2024 (USD Million)

4.2.3.  Robotic

4.2.3.1.    Market size, by region, 2013-2024 (USD Million)

4.3. Needle based biopsy guns

4.3.1.  Market size, by region, 2013-2024 (USD Million)

4.3.2.  Vacuum-assisted Biopsy (VAB) Devices

4.3.2.1.  Market size, by region, 2013-2024 (USD Million)

4.3.3.  Fine Needle Aspiration Biopsy (FNAB) Devices

4.3.3.1.  Market size, by region, 2013-2024 (USD Million)

4.3.4.  Core Needle Biopsy (CNB) devices

4.3.4.1.  Market size, by region, 2013-2024 (USD Million)

4.4. Biopsy needles

4.4.1.  Market size, by region, 2013-2024 (USD Million)

4.4.2.  Reusable

4.4.2.1.  Market size, by region, 2013-2024 (USD Million)

4.4.3.  Disposable

4.4.3.1.  Market size, by region, 2013-2024 (USD Million)

4.5. Biopsy forceps

4.5.1.  Market size, by region, 2013-2024 (USD Million)

4.5.2.  General Biopsy Forceps

4.5.2.1.  Market size, by region, 2013-2024 (USD Million)

4.5.3.  Hot Biopsy Forceps

4.5.3.1.  Market size, by region, 2013-2024 (USD Million)

4.6. Others

4.6.1.  Market size, by region, 2013-2024 (USD Million)

4.6.2.  Brushes

4.6.2.1.  Market size, by region, 2013-2024 (USD Million)

4.6.3.  Curettes

4.6.3.1.  Market size, by region, 2013-2024 (USD Million)

4.6.4.  Punches

4.6.4.1.  Market size, by region, 2013-2024 (USD Million)

Chapter 5.  Biopsy Devices Market, By End-User

5.1. Key segment trends

5.2. Hospitals

5.2.1.  Market size, by region, 2013-2024 (USD Million)

5.3. Ambulatory surgical centers

5.3.1.  Market size, by region, 2013-2024 (USD Million)

5.4. Others

5.4.1.  Market size, by region, 2013-2024 (USD Million)

Browse complete Table of Contents (ToC) of this research report @ https://www.decresearch.com/toc/detail/biopsy-devices-market